Neion Bio

Neion Bio is a biotechnology company dedicated to advancing drug discovery for ion channels, a challenging but high-value class of therapeutic targets. The company utilizes a proprietary platform that integrates high-resolution Cryo-Electron Microscopy (Cryo-EM) with computational chemistry and artificial intelligence to design highly selective small molecules. Founded by pioneers in structural biology and sensory physiology, Neion Bio focuses on addressing unmet needs in chronic pain and other neurological conditions. Their structural approach allows for the precise mapping of binding sites, enabling the development of next-generation modulators with improved safety and efficacy profiles. The company's methodology aims to overcome the limitations of traditional screening by providing direct visualization of drug-target interactions at the atomic level.